Peptides are rapidly gaining traction within the wellness, longevity, and startup communities, particularly among younger entrepreneurs and biohacking enthusiasts in San Francisco. Startups and investors are increasingly embracing gray-market peptides despite ongoing medical concerns, regulatory uncertainty, and the lack of FDA approval for many of the compounds being promoted for energy, muscle growth, recovery, and anti-aging purposes. Peptide-focused events, online communities, and wellness ventures are also rapidly emerging as commercialization of the trend continues to expand.
In an article with The San Francisco Standard, Jesse Dresser discusses the legal and regulatory risks associated with peptides marketed for “research use only” while still being promoted for human consumption and wellness applications. He highlights the increasingly complex regulatory landscape surrounding peptide distribution, marketing, and compliance as the market continues to expand.
Read the full article in The San Francisco Standard.
